AiViva Biopharma, Inc. Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
AiViva Biopharma, Inc. is a privately held clinical-stage biotechnology company that develops therapies aiming to localize treatment and reduce systemic exposure through its proprietary JEL technology. The company focuses on dermatology, ophthalmology, urology, and oncology. It is located in Costa Mesa, California, and has between 11 and 50 employees. AiViva has reported a diverse product pipeline and development efforts, including AIV007 in combination with JEL technology, and has conducted a Phase 1/2a study of AIV001 for dermal scarring. In September 2023, the company announced the appointment of Dr. Lester J. Kaplan to its board of directors.